M, C., D, B., R, V., & G, S. (2019). New horizons for the treatment of severe, eosinophilic asthma: Benralizumab, a novel precision biologic. Dove Medical Press.
Chicago Style (17th ed.) CitationM, Caminati, Bagnasco D, Vaia R, and Senna G. New Horizons for the Treatment of Severe, Eosinophilic Asthma: Benralizumab, a Novel Precision Biologic. Dove Medical Press, 2019.
MLA (8th ed.) CitationM, Caminati, et al. New Horizons for the Treatment of Severe, Eosinophilic Asthma: Benralizumab, a Novel Precision Biologic. Dove Medical Press, 2019.
Warning: These citations may not always be 100% accurate.